204 related articles for article (PubMed ID: 22955689)
21. Serum YKL-40 is increased in patients with slow coronary flow.
Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
[TBL] [Abstract][Full Text] [Related]
22. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum YKL40 level is a predictor of MACE during the long-term follow up in hypertensive patients.
Çetin M; Erdoğan T; Kırış T; Özer S; Çinier G; Emlek N; Durak H; Şatıroğlu Ö
Clin Exp Hypertens; 2020; 42(3):271-274. PubMed ID: 31204510
[No Abstract] [Full Text] [Related]
24. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention.
Karataş MB; Çanga Y; Özcan KS; İpek G; Güngör B; Onuk T; Durmuş G; Öz A; Karaca M; Bolca O
Am J Emerg Med; 2016 Feb; 34(2):240-4. PubMed ID: 26585199
[TBL] [Abstract][Full Text] [Related]
25. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
[TBL] [Abstract][Full Text] [Related]
26. Increased red cell distribution width predicts occlusion of the infarct-related artery in STEMI.
Akboga MK; Yayla C; Yilmaz S; Sen F; Balci KG; Ozcan F; Aras D
Scand Cardiovasc J; 2016; 50(2):114-8. PubMed ID: 26651498
[TBL] [Abstract][Full Text] [Related]
27. [Dynamic changes of complement level in patients with acute coronary syndrome and its relationships with myocardial injury].
Shao A; Qi X; Li Q; Jia W; Wei L; Hou W; Qi Y; Liu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):515-519. PubMed ID: 28625240
[TBL] [Abstract][Full Text] [Related]
28. Serum apelin level predicts the major adverse cardiac events in patients with ST elevation myocardial infarction receiving percutaneous coronary intervention.
Liu HT; Chen M; Yu J; Li WJ; Tao L; Li Y; Guo WY; Wang HC
Medicine (Baltimore); 2015 Jan; 94(4):e449. PubMed ID: 25634182
[TBL] [Abstract][Full Text] [Related]
29. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.
Yamac AH; Sevgili E; Kucukbuzcu S; Nasifov M; Ismailoglu Z; Kilic E; Ercan C; Jafarov P; Uyarel H; Bacaksiz A
Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051
[TBL] [Abstract][Full Text] [Related]
30. [Association between CD137 and ischemia-reperfusion injury in patients with acute ST-segment elevation myocardial infarction].
Pan YJ; Chen R; Xu Y; Xia H; Xu C; Yuan W
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Dec; 49(12):1198-1205. PubMed ID: 34905897
[No Abstract] [Full Text] [Related]
31. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
[TBL] [Abstract][Full Text] [Related]
32. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
33. Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease.
Harutyunyan M; Johansen JS; Mygind ND; Reuter SB; Kastrup J
Biomark Med; 2014; 8(8):977-87. PubMed ID: 25343670
[TBL] [Abstract][Full Text] [Related]
34. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
[TBL] [Abstract][Full Text] [Related]
35. Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.
Kim HM; Lee BW; Song YM; Kim WJ; Chang HJ; Choi DH; Yu HT; Kang E; Cha BS; Lee HC
Cardiovasc Diabetol; 2012 Jul; 11():84. PubMed ID: 22809439
[TBL] [Abstract][Full Text] [Related]
36. Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction.
Fang C; Li J; Wang W; Wang Y; Chen Z; Zhang J
Front Med (Lausanne); 2023; 10():1158005. PubMed ID: 37283624
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Basar N; Sen N; Ozcan F; Erden G; Kanat S; Sokmen E; Isleyen A; Yuzgecer H; Ozlu MF; Yildirimkaya M; Maden O; Covic A; Johnson RJ; Kanbay M
J Investig Med; 2011 Aug; 59(6):931-7. PubMed ID: 21415772
[TBL] [Abstract][Full Text] [Related]
38. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
40. The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Kilic S; Kose S; Amasyali B; Isik E
Coron Artery Dis; 2005 Aug; 16(5):293-9. PubMed ID: 16000887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
